Try our beta test site

Open-Label Tolvaptan Study in Subjects With ADPKD (TEMPO 4/4)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.
ClinicalTrials.gov Identifier:
NCT01214421
First received: September 26, 2010
Last updated: March 23, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 2, 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):